Published January 2019 | Version v1
Journal article

Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides

  • 1. Department of Chemistry, Hunter College of the City University of New York, New York, NY (United States)
  • 2. Department of Chemistry, University of Nevada Las Vegas, Las Vegas, NV (United States)
  • 3. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (United States)
  • 4. Department of Chemistry, Graduate Center of the City University of New York, New York, NY (United States)

Description

A pentapeptide macrocyclic ligand, KYCAR (lysyl-tyrosyl-cystyl-alanyl-arginine), has been designed as a potential chelating ligand for SPECT imaging and therapeutic in vivo agents. This study shows the synthesis and characterization of KYCAR complexes containing nonradioactive rhenium, 99mTc, or 188Re. The metal complexes were also biologically evaluated to determine in vivo distribution in healthy mice. The overall goals of this project were (1) to synthesize the Tc/Re pentapeptide complexes, (2) to identify spectroscopic methods for characterization of syn versus anti rhenium peptide complexes, (3) to analyze the ex vivo stability, and (4) to assess the biological properties of the [99mTc]TcO-KYCAR and [188Re]ReO-KYCAR complexes in vivo. Details on these efforts are provided below.

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2018.11.001;
PII
S0969805118301471;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
68
Journal Page Range
p. 1-13
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.